-
Cy5-UTP: Making Brain-Targeted mRNA Visible
2026-09-10
Cy5-UTP turns RNA synthesis into a measurable experimental variable, helping translational researchers connect T7-based RNA probe synthesis with intranasal mRNA-LNP delivery, tissue localization, and functional validation.
-
HyperScribe All in One mRNA Synthesis Kit Plus 1
2026-09-09
Build translation-ready, modified mRNA with co-transcriptional ARCA capping, 5mCTP, ψUTP, DNase treatment, and enzymatic poly(A) tailing in one coordinated workflow. The kit is especially useful for RNA vaccine development, modified-mRNA translation assays, and reproducible RNA biology experiments where cap, tail, and innate-sensing variables must be controlled together.
-
1-methyl Adenosine for Reliable Cell Assays
2026-09-09
Learn how 1-methyl Adenosine (SKU C5753) can support better-controlled viability, proliferation, cytotoxicity, and RNA modification workflows. This scenario-based guide connects practical stock preparation and assay design with quantitative UHPLC-MS/MS evidence for 1-methyl Ado measurement.
-
Bi-Layer Tranexamic Acid Dressings for Hemostasis
2026-09-08
The reference study develops a bi-layer wound dressing that combines Tranexamic Acid, an NO donor, and propolis to address hemorrhage and bacterial contamination simultaneously. Its results support rapid fibrin stabilization and strong antibacterial activity in laboratory assays, while also highlighting the need for animal and clinical validation.
-
Pravastatin Sodium: Applied Assay Workflows
2026-09-08
Pravastatin sodium enables controlled cholesterol biosynthesis inhibition across biochemical, macrophage, hepatocyte, and metabolic disease workflows. This guide converts its selective HMG-CoA reductase activity into practical dosing, transporter-aware controls, and troubleshooting strategies for LDL cholesterol reduction and translational screening.
-
YC-1 Hypoxia Research: Workflow and Troubleshooting
2026-09-07
Build reproducible hypoxia, HIF-1α, cGMP, and cancer-cell assays with YC-1 while separating pathway modulation from nonspecific cytotoxicity. This guide translates a neurobiology study’s orthogonal design into practical controls for tumor angiogenesis inhibition and apoptosis research.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-09-05
Build a ratiometric mitochondrial membrane potential assay workflow for apoptosis, drug screening, and immuno-oncology models. This guide explains how to use CCCP controls, standardize JC-1 imaging or flow cytometry, and interpret mitochondrial depolarization alongside the immune findings reported for glabridin-gold(I) complex 6d.
-
BRD4770: Reading G9a Inhibition in Cancer Cells
2026-09-05
BRD4770 is a G9a histone methyltransferase inhibitor for dissecting H3K9 methylation, senescence, and cancer-cell growth. This guide builds beyond routine viability testing by showing how to connect target engagement with defensible phenotypic interpretation.
-
Trichostatin A (TSA): Practical Lab Guide
2026-09-04
Trichostatin A (TSA) provides a reversible HDAC-inhibition approach for studying histone acetylation, cell-cycle responses, differentiation, and cancer-related phenotypes in cultured cells. It is suitable for controlled in vitro research and carefully justified animal studies, but product-dossier concentrations should not be treated as universal dosing guidance or clinical evidence.
-
Dibutyryl-cAMP in Astrocyte Reprogramming
2026-09-04
Astrocyte-to-motoneuron reprogramming is moving from transcription-factor design toward controllable cell-state engineering. This article examines how Dibutyryl-cAMP, sodium salt can serve as a mechanistic perturbation tool for testing cAMP-dependent signaling during lineage conversion, while distinguishing evidence from translational hypotheses.
-
Indole-3-pyruvic acid in Reliable Cell Assays
2026-09-03
Learn how Indole-3-pyruvic acid (SKU C8759) can be integrated into viability, proliferation, cytotoxicity, plant hormone, and immune-model workflows without confusing metabolic effects with assay artifacts. This scenario-based guide connects practical handling parameters with evidence on AhR, TAA1, UHRF1, and AMPK biology.
-
Indole-3-pyruvic Acid Feedback in Auxin Biosynthesis
2026-09-03
The 2022 PNAS study identified indole-3-pyruvic acid (IPyA, also commonly abbreviated IPA) as a negative-feedback regulator of TAA1/TAR aminotransferases in the two-step auxin pathway. By combining enzyme kinetics, chemical perturbation, and plant evidence across Arabidopsis, rice, and tomato, the work explains how plants coordinate IPyA production with its conversion to indole-3-acetic acid.
-
nor-NOHA Acetate: Arginase Research Workflows
2026-09-02
Build controlled arginine-metabolism experiments with reversible nor-NOHA inhibition, from HepG2 phenotyping to endothelial signaling assays. The workflow also shows how to position nor-NOHA acetate as an exploratory metabolic variable alongside the CD36-driven immune-escape program reported in AML.
-
CD36 Lipid Signaling Drives Immune Escape in AML
2026-09-02
A 2024 Cell Reports Medicine study identifies a non-canonical CD36 lipid-sensing program that enables AML cells to suppress T cell activity and resist decitabine-associated immune effects. The work connects oxidized LDL and palmitate uptake to TLR4–LYN–MYD88–NF-κB signaling and shows that statin-mediated lipid restriction can improve decitabine efficacy in preclinical models.
-
Cathepsin B inhibitor CA-074: Lab Scenarios
2026-09-01
This scenario-driven guide explains how Cathepsin B inhibitor CA-074 (SKU A1926) can improve the interpretation and reproducibility of cell viability, cytotoxicity, and lysosomal cell-death experiments. It connects biochemical selectivity, formulation, controls, and recent necroptosis evidence to practical laboratory decisions.